Panmure Gordon & Company

for the 21st


Panmure Gordon is building a 21st century merchant bank that provides independent advice, research and execution services to UK growth and mid-cap corporates and investment companies, underpinned by long-term client relationships.

For over 140 years we have helped fast growing corporate and institutional clients achieve their ambitions. Integrity, excellence and experience are at the heart of everything Panmure Gordon does, in public or private markets and for equity or debt.

Our well-funded growth strategy is being delivered by our highly experienced team, to create a compelling offer for current and future clients.

We are also a registered broker-dealer in the United States.

To learn more about how we can help you achieve your goals, please contact us.

a selection of client transactions

We are proud to work with some of the most exciting growth and mid-cap companies in the UK to help them achieve their ambitions. Here are a few of our client transactions.

Feb 2019

MaxCyte Inc

Secondary Offering

Financial Adviser, Nominated Adviser and Broker

£10 million

Feb 2019

Midatech Pharma plc

Secondary Offering

Financial Adviser, Nominated Adviser and Broker

£12.7 million

Oct 2018

Harvey Nash Group plc

Recommended Cash Offer by The Power of Talent Ltd

Joint Financial Adviser and Sole Broker

£99 million

Oct 2018

CareTech Holdings plc

Acquisition of Cambian Group plc

Joint Financial Adviser and Broker

£372 million

May 2018

LoopUp Group plc

Reverse takeover of Meeting Zone

Lead Financial Adviser, Nominated Adviser and Joint Broker

£234 million

APR 2018

Escher Group Holdings plc

Recommended Cash Offer by Hanover Investors Management Ltd

Financial Adviser, Nominated Adviser and Broker

£35 million

“CareTech has worked with Panmure Gordon for many years and they have advised us on numerous successful transactions. When contemplating transformational M&A, we wanted Panmure Gordon, our trusted adviser, at our side from the outset. The Panmure Gordon team delivered regulatory advice that was both precise and commercial, as well as clear and effective shareholder communication. The team are professional, proactive and committed to helping our business achieve its aims.”

Farouq Sheikh, Founder & Executive Chairman, CareTech